Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,865.00    170.00 (2.54%)
Bid:
6,865.00
Ask:
6,875.00
Spread: 10.00 (0.146%)
Market Cap: £5.07b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

9 Nov 2009 07:00

RNS Number : 1535C
Spirax-Sarco Engineering PLC
09 November 2009
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Monday 9th November 2009

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the period since 1st July 2009.

Trading

Since the half year, the pace of decline in our sales has stabilised. Sales for the year to date through October were down 9% in constant currency against strong results last year. Exchange rates have continued to be favourable and have added 10% to Group revenues in 2009 compared with average exchange rates in calendar year 2008.

Trading margin this year has benefited from exchange rates and, since the end of the half year, has benefited from lower materials costs and reduced operating costs. We have completed the announced headcount reductions which, together with further attrition, means our headcount is now 7% lower than the start of the year. The reductions are largely in manufacturing and administrative support, with cost benefits in the second half year and continuing to be delivered in 2010.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 31st October 2009 of £1m despite funding the acquisition of MasoSine in August for £22m and Intervalf in October for £3m. There has been no material change in the financial position of the Group during the period. Capital investment is well above the level in recent years as we continue to invest in projects with good returns to deliver more efficient manufacturing processes and capacity expansion, particularly in developing markets.

Outlook

Our strong cash position has enabled us to continue to make investments in developing new products, expanding our market penetration and improving operating efficiency, even through this difficult period. The Group's strong customer value proposition and diversity of end user markets, customers, products and geographic spread, give us confidence in our future prospects.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBXUGGGCL
Date   Source Headline
21st Jul 201510:18 amRNSListing Application
21st Jul 20158:41 amRNSDirector/PDMR Shareholding
9th Jul 20153:22 pmRNSNotice of Results
2nd Jul 201510:00 amRNSAcquisition
19th Jun 20153:00 pmRNSHolding(s) in Company
18th Jun 20153:30 pmRNSDirector/PDMR Shareholding
18th Jun 201512:22 pmRNSHolding(s) in Company
18th Jun 201511:48 amRNSHolding(s) in Company
12th Jun 20153:50 pmRNSShare Consolidation
11th Jun 201512:37 pmRNSAmendment to Official List & Share Consolidation
10th Jun 20153:55 pmRNSAdditional Listing
9th Jun 20153:54 pmRNSAdditional Listing
2nd Jun 20153:56 pmRNSDirector/PDMR Shareholding
11th May 20155:00 pmRNSResult of AGM
11th May 20157:00 amRNSAGM Statement
1st May 20154:27 pmRNSDirector/PDMR Shareholding
1st May 20154:11 pmRNSNotification of Release Date
23rd Apr 20155:56 pmRNSHolding(s) in Company
21st Apr 20153:51 pmRNSDirector/PDMR Shareholding
21st Apr 20157:00 amRNSQueen's Award for Enterprise
9th Apr 20158:34 amRNSAcquisition
30th Mar 20155:05 pmRNSDirector/PDMR Shareholding
11th Mar 20154:29 pmRNSDirector/PDMR Shareholding
5th Mar 20157:01 amRNSSpirax Sarco to start direct operations in India
5th Mar 20157:00 amRNS2014 Preliminary Results
13th Jan 20154:12 pmRNSHolding(s) in Company
13th Jan 20154:11 pmRNSTotal Voting Rights
2nd Dec 201410:34 amRNSDirector/PDMR Shareholding
18th Nov 20144:08 pmRNSHolding(s) in Company
18th Nov 20144:07 pmRNSHolding(s) in Company
12th Nov 20144:41 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSInterim Management Statement
4th Nov 20144:13 pmRNSTotal Voting Rights
4th Nov 20144:13 pmRNSHolding(s) in Company
13th Oct 20144:59 pmRNSDirector/PDMR Shareholding
6th Oct 201411:57 amRNSTotal Voting Rights
1st Oct 201410:00 amRNSNotification of Key Date
22nd Sep 20145:15 pmRNSDirector/PDMR Shareholding
10th Sep 20147:00 amRNSCET signs Heads of Terms with Spirax Sarco
4th Sep 20143:31 pmRNSTotal Voting Rights
28th Aug 20144:25 pmRNSHolding(s) in Company
19th Aug 20144:14 pmRNSDirector/PDMR Shareholding
7th Aug 20147:00 amRNSHalf Yearly Report
6th Aug 20142:13 pmRNSTotal Voting Rights
25th Jul 20142:05 pmRNSHolding(s) in Company
7th Jul 20143:25 pmRNSNotification of Key Dates
2nd Jul 20143:43 pmRNSTotal Voting Rights
25th Jun 20143:05 pmRNSHolding(s) in Company
23rd Jun 20148:49 amRNSHolding(s) in Company
12th Jun 20148:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.